Condition: Cognitive Impairment · Cognitive Decline · Radiotherapy Side Effect · Sponsor: Region Stockholm
Randomized, placebo-controlled, double-blinded, parallel group clinical trial to investigate if 6 months of oral lithium tablets (S-lithium 0,5-1,0 mmol/l) will prevent cognitive decline after brain radiotherapy in pediatric brain tumor survivors. Primary outcome measure is Processing Speed Index (PSI) 2 years after start of study treatment.
This description comes directly from the study's public registry record.
Klas Blomgren, MD, Professor · 0046703233353 · klas.blomgren@regionstockholm.se
Gustaf Hellspong, MD, PhD Student · 0707308144 · gustaf.hellspong@regionstockholm.se
Always discuss trial participation with your own doctor first.
| Karolinska Universitetssjukhuset | Solna, Stockholm County, Sweden | Not Yet Recruiting |
| HOPE | Stockholm, Sweden | Recruiting |
Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.
We email about this public record only. Unsubscribe anytime with one click. Never medical advice.
This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.
Source record: clinicaltrials.gov/study/NCT06051240